Market Cap

Australian Clinical Labs Ltd Market Capitalization:

A$514.7 Million

AUD as of July 1, 2024

US$342.8 Million

business Australian Clinical Labs Ltd Company Profile

Australian Clinical Labs Ltd Main Stock Listing

ASX: ACL

Market Capitalization History of Australian Clinical Labs Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $204.45 B
Danaher $177.21 B
Siemens Healthineers AG $63.84 B
DexCom, Inc. $45.21 B
Lonza Group Ltd $39.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Australian Clinical Labs Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$577.2 M -8.04%
Jan. 1, 2023 A$627.7 M -40.47%
Jan. 1, 2022 A$1.05 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Australian Clinical Labs Ltd Categories

Australia languages Healthcare languages Diagnostics & Research
Australia Healthcare Australia Diagnostics & Research

Stocks & Indices

Australian Clinical Labs Ltd has the following listings and related stock indices.


Stock: ASX: ACL

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.